Companies / Dbv Technologies S.A.
Dbv Technologies S.A.
Financials ยท FY2025
Ownership
296.1M shares outstanding ยท as of Jul 16, 2026
Ownership
| 10%+ / strategic | 1.12% | 3,309,055 |
| Institutions | 4.65% | 13,778,624 |
| Public float | 94.23% | 278,973,818 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 7
View all โ| Insider | % of shares | Shares |
|---|---|---|
667, L.P.FormerDirector | โ | โ |
Baker Bros. Advisors (GP) LLCFormerDirector | โ | โ |
Baker Bros. Advisors LPFormerDirector | โ | โ |
Baker Brothers Life Sciences LPFormerDirector | โ | โ |
Baker FelixFormerDirector | โ | โ |
Baker JulianFormerDirector | โ | โ |
Mohideen PharisChief Medical Officer | โ | โ |
Institutional holders 59
View all โ| Holder | Value | % of shares |
|---|---|---|
| $63.43M | 1.12% | |
| $47.19M | 0.83% | |
| $35.61M | 0.63% | |
| $30.53M | 0.49% | |
| $20.15M | 0.33% | |
| $19.11M | 0.34% | |
| $12.26M | 0.22% | |
| $11.01M | 0.19% | |
| $10.54M | 0.19% | |
| $8.71M | 0.15% |
Activity
Jun 30, 2026View all โ
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares ฮ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Perceptive Advisors LLC 13F manager | New | ADR | $20.15M | +964K | 964,391 0.33% of shares | medium |
| Q1 2026 as of | Millennium Management LLC 13F manager | Trim | ADR | $-6.73M | -322K -50.23% | 318,959 0.11% of shares | medium |
| Q1 2026 as of | Dorsey Wright & Associates 13F manager | New | ADR | $2.14M | +103K | 102,550 0.03% of shares | low |
| Q2 2026 as of | Deutsche Bank AG 13F manager | New | ADR | $971.5K | +59K | 59,240 0.02% of shares | low |
| Q2 2026 as of | LPL Financial LLC 13F manager | New | ADR | $881.5K | +54K | 53,751 0.02% of shares | low |
| Q1 2026 as of | Two Sigma Investments, LP 13F manager | Exit | ADR | $-650.8K | -34K -100.00% | 0 | low |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | Exit | ADR | $-401.8K | -21K -100.00% | 0 | low |
| Q1 2026 as of | HighVista Strategies LLC 13F manager | Exit | ADR | $-304.4K | -16K -100.00% | 0 | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Janus Henderson Group PLC | Passive13G/A | โ |
| Citadel Advisors LLC | Passive13G/A | โ |
| Artisan Partners Asset Management Inc. | Passive13G | โ |
| Venrock Healthcare Capital Partners II, L.P. | Passive13G/A | โ |
| Vivo Opportunity Fund Holdings, L.P. | Passive13G/A | โ |
| Invus, L.P. | Passive13G/A | โ |
| MPM BioImpact LLC | Passive13G | โ |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| DBVT | ADR | 23306J309 |